Literature DB >> 28534422

Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology.

Nana Pogosova1,2, Kornelia Kotseva1,3,4, Dirk De Bacquer1,4, Roland von Känel5,6, Delphine De Smedt4, Jan Bruthans1,7,8, Maryna Dolzhenko9.   

Abstract

Background Depression and anxiety are established psychosocial risk factors for coronary heart disease. Contemporary data on their prevalence and associations with other risk factors were evaluated as part of the EUROASPIRE IV survey. Design The design of this study was cross-sectional. Methods The study group consisted of 7589 patients from 24 European countries examined at a median of 1.4 years after hospitalisation due to coronary heart disease events. Depression and anxiety were assessed using the Hospital Anxiety and Depression Scale. Results Symptoms of anxiety (Hospital Anxiety and Depression Scale-Anxiety score ≥8) were seen in 26.3% of participants and were more prevalent in women (39.4%) vs men (22.1%). Of the patients, 22.4% (30.6% of women and 19.8% of men) had symptoms of depression (Hospital Anxiety and Depression Scale-Depression score ≥8). Nevertheless, antidepressants and anti-anxiety medications were prescribed to only 2.4% of patients at hospital discharge, and 2.7% and 5.0% of patients, respectively, continued to take them at interview. Both anxiety and depression were associated with female gender, lower educational level and more sedentary lifestyle. Anxiety was more prevalent in younger age groups and depression rates increased with advancing age. Depression was positively associated with current smoking, central obesity and self-reported diabetes. A number of positive lifestyle changes reduced the odds of anxiety and depression. Conclusions A substantial proportion of patients have anxiety and depression symptoms after coronary heart disease events but these conditions are undertreated. These disorders, especially depression, are associated with other risk factors, including educational level, sedentary lifestyle, smoking, unhealthy diet and reduced compliance with risk factor modification.

Entities:  

Keywords:  Anxiety; cardiovascular risk; coronary artery disease; depression

Mesh:

Year:  2017        PMID: 28534422     DOI: 10.1177/2047487317711334

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  22 in total

Review 1.  Significance of psychosocial factors in cardiology: update 2018 : Position paper of the German Cardiac Society.

Authors:  Christian Albus; Christiane Waller; Kurt Fritzsche; Hilka Gunold; Markus Haass; Bettina Hamann; Ingrid Kindermann; Volker Köllner; Boris Leithäuser; Nikolaus Marx; Malte Meesmann; Matthias Michal; Joram Ronel; Martin Scherer; Volker Schrader; Bernhard Schwaab; Cora Stefanie Weber; Christoph Herrmann-Lingen
Journal:  Clin Res Cardiol       Date:  2019-05-10       Impact factor: 5.460

Review 2.  A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment.

Authors:  Danielle Rome; Alyssa Sales; Rebecca Leeds; John Usseglio; Talea Cornelius; Catherine Monk; Kim G Smolderen; Nathalie Moise
Journal:  Curr Atheroscler Rep       Date:  2022-06-25       Impact factor: 5.967

3.  The association between cardiac drug therapy and anxiety among cardiac patients: results from the national DenHeart survey.

Authors:  Camilla Rotvig; Anne Vinggaard Christensen; Knud Juel; Jesper Hastrup Svendsen; Martin Balslev Jørgensen; Trine Bernholdt Rasmussen; Britt Borregaard; Lars Thrysoee; Charlotte Brun Thorup; Rikke Elmose Mols; Selina Kikkenborg Berg
Journal:  BMC Cardiovasc Disord       Date:  2022-06-20       Impact factor: 2.174

Review 4.  [Evidence-based recommendations for the treatment of depressive comorbidity in somatic illness].

Authors:  C Albus; F Geiser
Journal:  Internist (Berl)       Date:  2019-12       Impact factor: 0.743

Review 5.  The association of depression following percutanous coronary intervention with adverse cardiovascular events: Protocol for a systematic review and meta-analysis.

Authors:  Yanfei Liu; Yinke Zhao; Jinfan Tian; Tiejun Tong; Rui Gao; Yue Liu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Associations of depression-anxiety and dyslipidaemia with subclinical carotid arterial disease: Findings from the Whitehall II Study.

Authors:  Elizabeth A Ellins; Martin J Shipley; D Aled Rees; Andrew Kemp; John E Deanfield; Eric J Brunner; Julian P Halcox
Journal:  Eur J Prev Cardiol       Date:  2019-09-17       Impact factor: 7.804

7.  Knockdown of lncRNA ENST00000609755.1 Confers Protection Against Early oxLDL-Induced Coronary Heart Disease.

Authors:  Yi Sun; Shuna Huang; Chunyu Wan; Qishuang Ruan; Xiaoxu Xie; Donghong Wei; Guobo Li; Shaowei Lin; Huangyuan Li; Siying Wu
Journal:  Front Cardiovasc Med       Date:  2021-05-21

8.  Association of Depression and Anxiety With the 10-Year Risk of Cardiovascular Mortality in a Primary Care Population of Latvia Using the SCORE System.

Authors:  Rolands Ivanovs; Anda Kivite; Douglas Ziedonis; Iveta Mintale; Jelena Vrublevska; Elmars Rancans
Journal:  Front Psychiatry       Date:  2018-06-26       Impact factor: 4.157

9.  Different cardiovascular risk factors and psychosocial burden in symptomatic women with and without obstructive coronary artery disease.

Authors:  Regina E Konst; Suzette E Elias-Smale; Anneke Lier; Christina Bode; Angela Hem Maas
Journal:  Eur J Prev Cardiol       Date:  2018-11-15       Impact factor: 7.804

10.  Xinkeshu Improves Endothelial Function and Augments Reendothelialization Capacity in Coronary Artery Disease with Anxiety/Depression.

Authors:  Jiapan Sun; Meiling Zhou; Guanghui Lv; Wenling Li; Yuanya Liu; Jiawen Liang; Jianning Zhang; Shijun Zhang; Yuanfei Deng; Jun Tao
Journal:  Oxid Med Cell Longev       Date:  2021-07-18       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.